Stroke recurrence in patients with patent foramen ovale: The Lausanne study

Neurology

Volumn 46, Issue 5, 1996, Pages 1301-1305

  Bogousslavsky, J ^a   Garazi, S ^a   Jeanrenaud, X ^a   Aebischer, N ^a   Van Melle, G ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULATION; ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM SEPTUM DEFECT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; SWITZERLAND; THROMBOCYTE AGGREGATION INHIBITION; TRANSIENT ISCHEMIC ATTACK; VALSALVA MANEUVER;

EID: 0029937025     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1301     Document Type: Article

References (34)

1. Biller J, Adams HP Jr, Johnen MR, et al. Paradoxical cerebral embolism: eight cases. Neurology 1986;36:1356-1360.
2. Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke 1987;18:856-862.
3. Jeanrenaud X, Bogousslavsky J, Payot M, Regli F, Kappenberger L. Foramen ovale perméable et infarctus cérébral du sujet jeune. Schweiz Med Wochenschr 1990;120:823-829.
4. Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L, for the Lausanne Stroke Registry Group. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: The Lausanne Stroke Registry. Neurology 1991;41:855-859.
5. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
6. Bogousslavsky J. Stroke in young adults. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: pathophysiology, diagnosis, and management. New York: Churchill Livingstone, 1992:895-901.
7. Webster MWI, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
8. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:1148-1152.
9. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and PFO as risk factors for cryptogenic stroke in patients less than 55 years of age. Stroke 1993;24:1865-1873.
10. Martin R, Bogousslavsky J. Embolic versus nonembolic causes of ischemic stroke. Cerebrovasc Dis 1995;5:70-74.
11. Stöllberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993;119:461-465.
12. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: Is stroke due to paradoxical embolism? Stroke 1993;24:31-34.
13. Jones HR, Caplan LR, Come PC, et al. Cerebral emboli of paradoxical origin. Ann Neurol 1983;13:314-319.
14. Jeanrenaud X, Kappenberger L. Patent foramen ovale and stroke of unknown origin. Cerebrovasc Dis 1991;1:184-192.
15. Garazi S, Bogousslavsky J, Jeanrenaud X, Van Melle G. Abnormal interatrial septum with stroke: recurrence risk and late prognosis in 103 patients [abstract]. Cerebrovasc Dis 1994;4:247.
16. Daniel WG. Transcatheter closure of patent foramen ovale: therapeutic overkill or elegant management for selected patients at risk? Circulation 1992;86:2013-2015.
17. Bridges ND, Hellensbrand W, Catson L, Filiano J, Newsburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86:1902-1908.
18. Devuyst J, Jeanrenaud X, Guffi M, et al. Surgical closure of patent foramen ovale (PFO) with stroke: a pilot study [abstract]. Cerebrovasc Dis 1995;5:239.
19. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of PFO in selected patients with cryptogenic stroke: a preliminary experience [abstract]. Stroke 1995;26:172.
20. Bogousslavsky J, Van Melle G, Regli F, for the Lausanne Stroke Registry. Analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
21. Belkin RN, Kisslo J. Atrial septal aneurysm: recognition and clinical relevance. Ann Heart J 1990;120:948-957.
22. Schneider B, Hanrath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990;16:1000-1009.
23. Pearson AC, Labovitz AJ, Tatineri S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17:66-72.
24. Pearson AC, Nagelhout D, Castello R, Gomez C, Labovitz A. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-1229.
25. Landi G, D'Angelo A, Boccardi E, et al. Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability. Arch Neurol 1992;49:279-283.
26. Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 1992;10:113-124.
27. Nater B, Bogousslavsky J, Regli F, Stauffer JC. Stroke patterns with atrial septal aneurysm. Cerebrovasc Dis 1992;2: 342-346.
28. Lucas C, Leys D, Monnier-Vehier F, Hénon H, Pruvo JP. Stroke patterns in patients with atrial septal aneurysm and ischemic stroke of unknown cause. Cerebrovasc Dis 1994;4: 337-340.
29. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-786.
30. The French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with PFO or ASA and cryptogenic stroke or TIA [abstract]. Cerebrovasc Dis 1994;4:247.
31. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane TEE study. Stroke 1994;25: 582-586.
32. Anzola GP, Remaldini E, Magoni M, Costa A, Cobelli M, Guindani M. Validation of TCD sonography in the assessment of patent foramen ovale. Cerebrovasc Dis 1995;5:194-198.
33. Weslow RG, Di Tullio MR, Sacco RL, et al. PFO in cryptogenic stroke patients is larger than in stroke-free controls [abstract]. Stroke 1995;26:175.
34. Comess KA, De Rook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994;23: 1598-1603.